Prevalence and Incidence of Peptidic growth factors deficiency

Peptidic growth factors deficiency: Rare Disease

Peptidic growth factors deficiency is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Peptidic growth factors deficiency, or a subtype of Peptidic growth factors deficiency, affects less than 200,000 people in the US population.

Ophanet, who are a consortium of European partners, currently defines a condition rare when if affects 1 person per 2,000. They list Peptidic growth factors deficiency as a "rare disease". More information about Peptidic growth factors deficiency is available from Orphanet

About prevalence and incidence statistics:

The term 'prevalence' of Peptidic growth factors deficiency usually refers to the estimated population of people who are managing Peptidic growth factors deficiency at any given time. The term 'incidence' of Peptidic growth factors deficiency refers to the annual diagnosis rate, or the number of new cases of Peptidic growth factors deficiency diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Search Specialists by State and City